

Cover Story
By Katie McKinney
This may not be the sort of targeted therapy Texas healthcare institutions wish to be known for, but starting Aug. 1, visitors to designated areas at MD Anderson Cancer Center, UT Southwestern, and UT Health Science Center at San Antonio will be able to carry their guns.
By Laura Brawley
In Brief


Drugs & Targets
Trending Stories
- Vinay Prasad’s CV inaccurately claims past membership on the President’s Cancer Panel
- Breakthrough Therapy designation, ASCO plenary, and NEJM publication notwithstanding, breast cancer drug camizestrant gets a No from ODAC
- FDA’s second rejection of Replimune’s melanoma treatment stirs worry among oncologists, patients
“Patients are owed another review.” - CBER Director Vinay Prasad dared to “say no to drugs”
- J. Craig Venter’s work was foundational to cancer advancement of the past 25 years
- Prasad’s “deceit,” plus, ODAC’s tough decision against biomarker-based progression assessment (for now)














